» Articles » PMID: 15739564

Biological Activity of Adult Cavernous Malformations: a Study of 56 Patients

Overview
Journal J Neurosurg
Specialty Neurosurgery
Date 2005 Mar 3
PMID 15739564
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Object: Cerebral cavernous malformations (CCMs) have previously been considered as congenital and biologically static malformations. On the other hand, the potential for growth and de novo generation of CCMs have also been reported. It is therefore important to study the proliferative and neoangiogenetic capacity of these lesions.

Methods: The authors studied the surgical specimens of 56 CCMs (23 deep and 33 superficial) obtained from adult patients. The proliferative activity of the endothelium and the neoangiogenetic capacity of these lesions were considered through immunohistochemical anaylsis of proliferating cell nuclear antigen (PCNA), MIB-1, Flk-1, vascular endothelial growth factor (VEGF), hypoxia-inducible factor (HIF)-1alpha, and endoglin antibodies. Positive immunostaining of endothelial cells occurred in 86% of patients for PCNA and in 38% of the cases for MIB 1. The expression of Flk-1 was observed in the endothelium of 71% of the cases, for VEGF in 41%, for HIF-1 alpha in 48.1%, and for endoglin in 63.6% of the cases. The correlation of immunohistochemical and clinical data indicated that VEGF was expressed in significantly less deep-seated lesions when compared with superficial CCMs. Neither the expression of the proliferative markers nor the expression of the angiogenetic antibodies correlated with patient age at surgery, sex, or the number of recent prior hemorrhagic episodes in the patients.

Conclusions: The CCMs from adult patients are active lesions exhibiting endothelial proliferation and neoangiogenesis. According to the data in this study, neoangiogenesis is more prominent in superficial CCMs than in deep-seated CCMs and is not associated with recent prior hemorrhages.

Citing Articles

Surgical treatment of cavernous malformation-related epilepsy in children: case series, systematic review, and meta-analysis.

Bosisio L, Cognolato E, Nobile G, Mancardi M, Nobili L, Pacetti M Neurosurg Rev. 2024; 47(1):251.

PMID: 38819574 DOI: 10.1007/s10143-024-02491-0.


Supratentorial cavernoma and epilepsy: Experience with 23 cases and literature review.

Khallaf M, Abdelrahman M Surg Neurol Int. 2019; 10:117.

PMID: 31528453 PMC: 6744744. DOI: 10.25259/SNI-178-2019.


Surgical Treatment of Vascular Intramedullary Spinal Cord Lesions.

Ghobrial G, Liounakos J, Starke R, Levi A Cureus. 2018; 10(8):e3154.

PMID: 30345209 PMC: 6191006. DOI: 10.7759/cureus.3154.


Genome-Wide Sequencing Reveals MicroRNAs Downregulated in Cerebral Cavernous Malformations.

Kar S, Bali K, Baisantry A, Geffers R, Samii A, Bertalanffy H J Mol Neurosci. 2017; 61(2):178-188.

PMID: 28181149 DOI: 10.1007/s12031-017-0880-6.


De novo formation of cerebral cavernous malformation adjacent to existing developmental venous anomaly - an effect of change in venous pressure associated with management of a complex dural arterio-venous fistula.

Chakravarthy H, Lin T, Chen Y, Wu Y, Yeh C, Wong H Neuroradiol J. 2016; 29(6):458-464.

PMID: 27562580 PMC: 5131766. DOI: 10.1177/1971400916666558.